PF-Atlas › Исследования › China TCM
Исследования: China TCM (19)
19 публикаций в теме «China TCM», проиндексированных PF-Atlas из PubMed и мировых журналов.
- Exploring the anti-fibrotic effects of safflower in systemic sclerosis based on metabolomics and gut microbiota analyses. · Frontiers in pharmacology · 2026
- Reconfiguring the macrophage-centric intercellular network in pulmonary fibrosis: Emerging perspectives and therapeutic opportunities. · Pharmacological research · 2026
- Ophiopogon japonicus alleviates pulmonary fibrosis through modulation of HIF1A/TUBB3 axis-associated M2 macrophage polarization and arginine metabolic alterations. · Journal of ethnopharmacology · 2026
- Salvia miltiorrhiza Bunge Alleviates Pulmonary Fibrosis by Promoting Fibroblast Mitophagy. · Journal of ethnopharmacology · 2026
- Sinomenine regulates the AKT/FOXO3/GLUL pathway to inhibit pulmonary fibroblast-to-myofibroblast transition via α7nAChR against rheumatoid arthritis associated interstitial lung disease. · Pharmacological research · 2026
- Trilobatin Ameliorates Pulmonary Fibrosis by Directly Targeting MEK1 to Antagonize TGF-β-Driven Epithelial-Mesenchymal Transition. · European journal of pharmacology · 2026
- Combatting pulmonary fibrosis with Astragalus membranaceus: A review of active components and multifaceted mechanisms. · Chinese herbal medicines · 2026
- Areca catechu L. procyanidins alleviate pulmonary fibrosis by suppressing the TGF-β/Smad/ERK cascade: Validation of a traditional herbal medicine. · Journal of ethnopharmacology · 2026
- Yin-Huang-Qing-Fei-Capsule derived diosgenin and its optimized nanoconjugate target STAT3 against pulmonary fibrosis. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
- m A methylation regulatory network in pulmonary fibrosis: Molecular mechanisms from RNA stability to cellular phenotype transition . · Experimental and therapeutic medicine · 2026
- Ac-SDKP modulates apoptosis via HSP27 and the FAS/FASL and mitochondrial axes. · Animal models and experimental medicine · 2026
- Multi-layered target identification strategy of natural products: Daphnetin targets NQO1 and OPLAH in silicosis alleviation. · Journal of pharmaceutical analysis · 2026
- Thioredoxin-interacting protein in fibrotic diseases: Mechanisms and therapeutic strategies. · The international journal of biochemistry & cell biology · 2026
- Lung-Targeted Lipid Nanoparticles Delivery of Wogonin for Pulmonary Fibrosis in Mice via Modulation of Cellular Proteostasis. · International journal of nanomedicine · 2026
- Astilbin directly targets trimethylguanosine synthase 1 to enhance telomerase activity thus alleviating pulmonary fibrosis. · European journal of pharmacology · 2026
- Combination of Ophiopogonin D, Ginsenoside Rg1, and Ginsenoside Rg3 ameliorates idiopathic pulmonary fibrosis via inhibiting type 2 alveolar epithelial cell senescence and epithelial-mesenchymal transition. · Naunyn-Schmiedeberg's archives of pharmacology · 2026
- Ophiopogon japonicus polysaccharide ameliorates pulmonary fibrosis via gut microbiota-metabolite crosstalk. · Microbial pathogenesis · 2026
- Rosmarinic acid alleviates bleomycin-induced pulmonary fibrosis in mice by activating the Rap1 pathway. · Scientific reports · 2026
- Shegan Mahuang Decoction ameliorates pulmonary fibrosis progression by inhibiting CCL3-mediated NETosis. · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
Медицинская оговорка. Списки исследований приведены только для информации и не являются медицинской рекомендацией.